Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Gossamer Bio (GOSS) Profit After Tax (2022 - 2025)

Historic Profit After Tax for Gossamer Bio (GOSS) over the last 4 years, with Q3 2025 value amounting to -$48.2 million.

  • Gossamer Bio's Profit After Tax fell 5654.64% to -$48.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$156.2 million, marking a year-over-year decrease of 11795.89%. This contributed to the annual value of -$56.5 million for FY2024, which is 6856.36% up from last year.
  • Per Gossamer Bio's latest filing, its Profit After Tax stood at -$48.2 million for Q3 2025, which was down 5654.64% from -$38.3 million recorded in Q2 2025.
  • Gossamer Bio's Profit After Tax's 5-year high stood at $49.2 million during Q2 2024, with a 5-year trough of -$59.4 million in Q3 2022.
  • In the last 4 years, Gossamer Bio's Profit After Tax had a median value of -$42.5 million in 2023 and averaged -$39.3 million.
  • As far as peak fluctuations go, Gossamer Bio's Profit After Tax skyrocketed by 21585.09% in 2024, and later crashed by 17774.01% in 2025.
  • Over the past 4 years, Gossamer Bio's Profit After Tax (Quarter) stood at -$55.8 million in 2022, then rose by 13.66% to -$48.1 million in 2023, then surged by 31.4% to -$33.0 million in 2024, then tumbled by 46.0% to -$48.2 million in 2025.
  • Its Profit After Tax stands at -$48.2 million for Q3 2025, versus -$38.3 million for Q2 2025 and -$36.6 million for Q1 2025.